BERLIN-CHEMIE is an international research-based pharmaceutical company with its headquarters in Berlin, Germany. The company has subsidiaries in over 30 countries in Europe and Asia. In 2022, BERLIN-CHEMIE employed around 5,000 people worldwide and achieved sales of €1.5 billion. Since 1992 BERLIN-CHEMIE has been part of the Italian Menarini Group, a leading global family-owned pharmaceutical and diagnostics company with a presence in over 140 countries. The group's global reach extends across Europe, Central America, Africa, the Middle East and Asia and generates annual sales of over € 4.155 billion. For over 125 years Menarini has invested in the development and commercial distribution of pharmaceuticals in order to offer patients and doctors around the world a wide portfolio of products in the fields of cardiovascular, respiratory, gastroenterology, metabolism, infectious diseases and anti-inflammatory/analgesic therapies. Menarini is also heavily involved in the field of oncology, where several new molecules for the treatment of a wide range of tumours are currently under development. Within the Menarini Group, BERLIN-CHEMIE is responsible for the pharmaceutical business in Germany, Eastern Europe and the CIS region. In addition, Berlin hosts one of the Group’s central research and development sites. Are you interested in working with us? Discover all available positions with just one click on our Careers Portal: careers.berlin-chemie.de Netiquette & Privacy Notice: https://www.berlin-chemie.de/social-media-datenschutz-und-netiquette Imprint: www.berlin-chemie.com/imprint This profile is maintained by the Communication & Public Relations department.
